BindingDB logo
myBDB logout

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
24786387 58 Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies.EBI Momenta Pharmaceuticals Inc.
22929233 72 A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors.EBI The University of Queensland
22458531 58 Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis.EBI Progen Pharmaceuticals Limited
20128596 68 Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.EBI Progen Pharmaceuticals Limited
17981035 7 Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides.EBI Progen Pharmaceuticals Limited
15027859 37 Validation of molecular docking calculations involving FGF-1 and FGF-2.EBI Progen Industries Limited
16366604 16 Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).EBI Progen Industries Limited
15081013 24 Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries.EBI Progen Industries Ltd
16175541 22 An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2.BDB Progen Industries Ltd.